Gastroenteritis in Pediatric Population of Qatar

Gastroenteritis Clinical Trial

— GE  

Official title:

Epidemiology of Acute Gastroenteritis in the Pediatric Population in Qatar: Causes, Risk Factors, Burden of Disease, Sources and Preventable Measures

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03046342
• Other study ID #: 14-00045
• Status: Recruiting
• Start date: March 10, 2015
• Est. completion date: December 10, 2024

Study information

• Verified date: February 2023
• Source: Hamad Medical Corporation
• Contact: Dr.Khalid Alansari
• Phone: +974 55336166
• Email: kalansari1[@]hamad.qa
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Description:

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: December 10, 2024
• Est. primary completion date: September 10, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Months to 14 Years

Eligibility

Inclusion Criteria:

• All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever

Exclusion Criteria:

1. Cases of vomiting +/- fever only without diarrhea

2. Suspicion of surgical abdomen

3. Bile stained vomitus

4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency

5. Cases of Inflammatory bowel disease

6. Antibiotic associated diarrhea

7. Patients with immune deficiency

8. Patients with chronic diarrhea (>2 weeks of diarrhea)

9. Patients receiving long term medication for any disease

Related Conditions & MeSH terms

• Gastroenteritis

Intervention

Diagnostic Test:
• Molecular method (PCR)
Stool samples are being processed through molecular method (PCR) for children with GE. Epidemiology of acute Gastroenteritis in the pediatric population in Qatar

Locations

Country	Name	City	State
Qatar	Hamad medical corporation	Doha

Sponsors (1)

Lead Sponsor	Collaborator
Hamad Medical Corporation

Country where clinical trial is conducted

Qatar, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	sources of viral, bacterial and parasitic GE in the country	Prevalence of viral, bacterial and parasitic GE in children < 14 years of age in Qatar will be identified by molecular method sample processing	4 years
Secondary	seasonal variation of GE in qatar determination	seasonal variation of GE in qatar being determined by number of cases reported during each season	4 years
Secondary	comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine	comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine by detection of source of GE in vaccinated children by molecular method.	4 years